HH Biotechnology Holdings Company Stock
Equities
HHBT
US40423K1007
Real Estate Development & Operations
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | -.--% | -.--% | -.--% |
2016 | HH Biotechnology Holdings Company Announces the Resignation of Charles Mathews as Director | CI |
2016 | HH Biotechnology Holdings Company Announces Board Changes | CI |
Sales 2014 | 7.99M 10.96M | Sales 2015 | 7.99M 10.96M | Capitalization | 45.7M 62.71M |
---|---|---|---|---|---|
Net income 2014 | -4M -5.49M | Net income 2015 | 2M 2.74M | EV / Sales 2014 | 2.07 x |
Net Debt 2014 | 12.44M 17.08M | Net cash position 2015 | 5.19M 7.12M | EV / Sales 2015 | 5.07 x |
P/E ratio 2014 |
-0.95
x | P/E ratio 2015 |
18.1
x | Employees | 121 |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 99.35% |
Managers | Title | Age | Since |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 16-09-08 |
Li Rong Wang
DFI | Director of Finance/CFO | 61 | 16-09-08 |
Liang Zou
COO | Chief Operating Officer | 44 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sheng Jiang
CEO | Chief Executive Officer | - | 16-09-08 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.22K | |
+40.98% | 28.24B | |
-12.26% | 26.95B | |
+21.92% | 26.45B | |
+5.54% | 25.93B | |
+50.26% | 22.95B | |
+9.01% | 20.4B | |
-2.65% | 18.55B | |
+29.69% | 16.22B | |
-13.52% | 15.1B |
- Stock Market
- Equities
- HHBT Stock